Assoc. Prof. Dr. Jessica Fleming | Molecular Biomarkers | Best Researcher Award

Assoc. Prof. Dr. Jessica Fleming | Molecular Biomarkers | Best Researcher Award

The Ohio State University, United States.

Dr. Jessica L. Fleming, PhD, is an accomplished radiobiologist at the James Comprehensive Cancer Center, The Ohio State University. With over a decade of experience in translational oncology research, she specializes in molecular biomarkers and radiation therapy innovations. Dr. Fleming plays a key role in collaborative clinical and research initiatives, especially in glioma and FLASH radiotherapy. She is also a co-founder and former CEO of the Cap City Biohackers, demonstrating her entrepreneurial edge in biomedical innovation.

Profile

Scopus

πŸŽ“ Education

Dr. Fleming earned her PhD in Molecular, Cellular, and Developmental Biology from The Ohio State University in 2012, following a BS in Biology, Cum Laude, from Ashland University in 2006. Her strong academic foundation was supported by multiple fellowships and research opportunities during her undergraduate and graduate studies.

πŸ§ͺ Experience

Dr. Fleming currently serves as an Associate Radiobiologist at OSU, working with Dr. Arnab Chakravarti. Her journey at OSU began as a graduate student, advancing through postdoctoral research and senior research associate roles. She has led cutting-edge radiobiological studies and was integral to several major clinical protocols. Beyond academia, she was the CEO and Co-Founder of Cap City Biohackers, reflecting her commitment to science outreach and innovation.

πŸ”¬ Research Interests

Radiation oncology and molecular oncology, particularly adult gliomas and biomarkers

FLASH radiotherapy, clinical translation, and toxicity modeling

Tumor heterogeneity and resistance mechanisms

Translational research bridging lab discoveries and patient care

πŸ† Awards & Honors

πŸ₯‡ 2024 ASTRO Annual Meeting Abstract Award

πŸ… Columbus CEO Future 50 Award (2020)

πŸŽ– Best of ASTRO & Basic/Translational Science Abstract Award (2018)

πŸŽ“ Alumni Grants for Graduate Research (2012)

🧬 NSF REU Fellow (2005)

🌟 Track & Field Athletic Scholar and Presidential Scholar (2002–2006)

πŸ“š Selected Publications

Here are some of Dr. Fleming’s key publications, with citation and access details:

Fleming JL et al. (2025) – Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813 – Int J Radiat Oncol Biol Phys (Accepted)

Manring HR, Fleming JL et al. (2025) – FLASH Radiotherapy: From In Vivo Data to Clinical Translation – Hematol Oncol Clin N Am (PMID: 39828472)

Fleming JL, Chakravarti A. (2025) – Molecular Biomarkers in Adult Lower-Grade Gliomas – Cancer J, 31(1): e0758. (PMID: 39841423)
➀ Cited by: 2 articles

Kotecha R, Schiff D, Chakravarti A, Fleming JL et al. (2024) – Management of IDH-Mutated Gliomas – J Clin Oncol, 42(21): 2588-2598. (PMID: 38833641)
➀ Cited by: 15 articles

Becker AP, Becker V, McElroy J, Fleming J et al. (2024) – HMGB2 as Biomarker in Astrocytomas – Cancers (Basel), 16(8): 1516. (PMID: 38672598)
➀ Cited by: 7 articles

Dr. Nik Kuznetsov | Aging biology | Best Researcher Award

Dr. Nik Kuznetsov | Aging biology | Best Researcher Award

KI, UAEU, Sweden.

Dr. Nik Kuznetsov is a molecular biologist with extensive expertise in genomics, transcriptomics, and molecular diagnostics. With a Ph.D. in Molecular Biology, he has contributed significantly to biomedical research, space medicine, and drug discovery. His work spans gene expression profiling, biomarker discovery, personalized medicine, and microgravity research, with applications in immunology, aging, and neuroscience. Currently, he serves as a Senior Visiting Research Scientist at the United Arab Emirates University, continuing his cutting-edge research in human health and space biology.

Profile

Google Scholar

πŸŽ“ Education

Nik Kuznetsov holds a Ph.D. in Molecular Biology, where he specialized in advanced genomic applications and molecular mechanisms in cellular responses. Prior to this, he earned an M.Sc. in Biochemistry, gaining expertise in protein interactions, enzymatic pathways, and molecular signaling. His academic foundation was built with a B.Sc. in Cell Biology, focusing on cellular structures, genetic regulation, and biochemical processes. His multidisciplinary education has enabled him to contribute significantly to research in molecular genetics, bioinformatics, and space biomedicine.

πŸ§ͺ Professional Experience

A highly experienced molecular biologist, currently serving as a Senior Visiting Research Scientist at United Arab Emirates University, with a strong background in molecular genetics, biotechnology, and drug discovery. Previously, he worked as a Senior Research Specialist & Lab Manager at Karolinska Institute, Sweden (2014–2022), where he managed laboratory operations and contributed to cutting-edge biomedical research. His industry experience includes serving as a Senior Scientist in Drug Discovery & Development at InDex Pharmaceuticals, Sweden (2012–2013) and as a Research Scientist at InDex Pharmaceuticals AB & InDex Diagnostics AB (2002–2011), where he played a crucial role in molecular diagnostics and therapeutic innovations. His academic career began with postdoctoral fellowships at the Karolinska Institute (1999–2001) and the Marie Curie Research Institute, UK (1997–1998), supported by the Royal Society. His expertise encompasses molecular biology, biochemistry, and cell biology, with a strong focus on translational research and pharmaceutical development.

πŸ”¬ Research Interests

Genomics & Transcriptomics: RNA-seq, ChIP-seq, RIP-seq, gene expression profiling

Molecular Biology & Bioinformatics: DNA-protein interactions, biomarker discovery

Space Biology & Aging: T-cell response in microgravity, neurodegeneration in astronauts

Personalized Medicine: Drug discovery, nucleic acid-based therapies

Immunology & Inflammation: Role of T-cells in disease and adaptive immune responses

πŸ† Awards & Fellowships

2023: Best Presentation Award, UAE Microbiome 2023, Abu Dhabi, UAE

2018 – 2021: Swedish National Space Agency Research Grant, Sweden

2015 – 2020: Travel Grant Awards, Karolinska Institute, Sweden

1997 – 1998: Royal Society Postdoctoral Fellowship, UK

πŸ“š Selected Publications

Kuznetsov NV (2025). Expression of the p53 network aging-associated genes "shaken, not stirred" in a 3-week microgravity simulation human study. bioRxiv.

Kuznetsov NV, et al. (2025). An Update on Neuroaging on Earth and in Spaceflight. IJMS.

Kuznetsov NV, et al. (2025). Hallmarks of Brain Plasticity. Biomedicines.

Kuznetsov NV, et al. (2023). Reappraisal of the concept of accelerated aging in neurodegeneration and beyond. Cells.

Kuznetsov NV, et al. (2023). Exposure of volunteers to microgravity by dry immersion results in gene expression changes and adaptation of T cells. Science Advances.